 |
LIVING CELL TECHNOLOGIES LIMITED Company Summary |
Living Cell Technologies Ltd (LCT) is an advanced biotechnology company currently listed on the Australian Stock Exchange. LCT’s focus is on market-driven encapsulated living cell products, for the treatment of Huntington's disease, haemophilia and insulin-dependent diabetes. LCT’s business was formed in 1987 to research cell extraction and to develop procedures for advanced living-cell replacement therapies.
|
|
 |
COMPANY DATA |
 |
Fax |
(02) 9252 2487 |
 |
|
Principal Sector |
Health & Pharm |
|
|
Principal Industry |
Biotechnology |
|
|
Listed |
2004/09/01 |
|
|
Homepage |
www.lct.com.au |
|
| |
|
|
MARKETS |
|
|
|
|
|
NEWS |
 |
| |  Aust Market Wrap, (ASX: LCT), (ASX: QAN), (ASX: MBL), (ASX: GFF), (ASX: SHG), (ASX: NCK), (ASX: ALL) (OCT 22, 2007) | | Aust Market At Midday, (ASX: CIF), (ASX: LCT), (NYSE: JPM) (OCT 9, 2007) | | Aust Market Wrap, (ASX: WES), (ASX: CGJ), (ASX: TLS), (ASX: CNP), (ASX: CSH), (ASX: SMY), (ASX: LCT) (SEP 12, 2007) |
|
|
